NEW YORK (GenomeWeb News) – Clinical geneticists in Europe are concerned about the use of direct-to-consumer genetic tests by consumers who have not had in-person discussions with doctors or genetic counselors about these tests, according to a study published in Genome Medicine. The geneticists are particularly worried about when the results are related to serious or actionable health conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.